Siemens Healthineers partners with Novo on non-invasive MASH testing access
Siemens Healthineers and Novo announced a collaboration to raise MASLD/MASH awareness and expand access to non-invasive blood testing, including Siemens’ FDA-authorized ELF test for advanced fibrosis risk in MASH.
Siemens Healthineers and Novo said they are collaborating to raise awareness of MASLD/MASH and broaden access to non-invasive blood testing, including Siemens’ FDA-authorized ELF test for advanced fibrosis risk in MASH.